Manual of Clinical Nutrition

(Brent) #1

Manual of Clinical Nutrition Management III- 79 Copyright © 2013 Compass Group, Inc.


NEPHROTIC SYNDROME
Discussion
Nephrotic syndrome is characterized by urinary losses of albumin and other plasma proteins, resulting in
hypoalbuminemia. Nephrotic syndrome is caused by the failure of the glomerular capillary wall to act as an
impermeable barrier to plasma proteins. A 24-hour urinary protein excretion of 3.0 g or greater is indicative
of nephrotic syndrome (1,2). Nephrotic syndrome is associated with other metabolic disturbances including
hyperlipidemia caused by increased lipid synthesis and decreased lipid catabolism (2,3). Edema is caused by
sodium retention or imbalance, fluid retention, hypoalbuminemia, and underlying diseases such as renal,
cardiac, or liver disease (3). Causes of nephrotic syndrome include diabetes mellitus, infections, certain
medications, neoplasms, preeclampsia, and chronic allograft nephropathy (2).


Approaches (2,3) Rationale

Protein:
 Provide 0.8 to 1.0 g/kg of ideal
body weight.
 High–biological value protein
should contribute at least 50% of
protein intake.

In contrast to the treatment of protein-energy malnutrition, the
treatment of nephrotic syndrome does not include a high-protein
diet; a high-protein diet would not replenish plasma protein levels
and could cause further renal damage in patients who have
nephrotic syndrome (2,3). Mild protein restriction and provision of an
angiotensin-converting enzyme inhibitor diminish urinary protein
losses and increase serum albumin levels (2,3). Soy protein decreases
urinary protein excretion and blood lipid levels (2,4). Some studies
suggest that a low or very-low protein diet with essential amino acid
supplementation reduces proteinuria and improves protein
nutriture (5). The recommended protein intake for children who
have nephrotic syndrome is the Dietary Reference Intake for age
plus the amount of urinary protein loss. Children who have
persistent proteinuria may require 2.0 to 2.5 g/kg of protein per day
(3).

Sodium:
 See “Sodium-Controlled Diet” in
Section IF.

The level of sodium prescribed is based on the severity of edema and
hypertension. Sodium is usually restricted to 1 to 2 g/day,
depending on the severity of the patient’s signs and symptoms (3).
Fluid restriction is often necessary and should be based on the
patient’s symptoms. Diuretics can help maintain fluid and sodium
balance (3).

Energy:
 Calculate according to individual
needs.

The energy intake requirement is determined by the nutritional
evaluation and can be as high as35 kcal/kg (3). Complex
carbohydrates should be the primary source of energy intake (2).
Weight loss may be recommended for obese patients, because they
have an increased risk of comorbid diseases and complications.

Fat:
 Use the National Cholesterol
Education Program Adult
Treatment Panel III guidelines (2,3).
 Refer to Section C: “Medical
Nutrition Therapy for Disorders of
Lipid Metabolism” for the
Therapeutic Lifestyle Changes
(TLC) diet.
 Target <30% of energy from fat,
saturated fat <7% of total fat, and
cholesterol <200 mg/dL per day (2).

Hypercholesterolemia or hypertriglyceridemia) results from increased
lipid synthesis and decreased lipid catabolism (3). This disturbance
in lipid metabolism increases the risk for cardiovascular disease,
stroke, and progressive renal failure (2). A combination of statin
therapy and the Therapeutic Lifestyle Changes diet lowers serum
lipid levels (2). Fish oil supplementation (12 g/day) may be
beneficial for patients who have IgA nephropathy, which is a caused
by the deposition of immunoglobin A in the kidneys (3).
Free download pdf